Compugen Ltd.
corporate_fare Company Profile
Compugen Ltd. (NASDAQ:CGEN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for CGEN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-18, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for CGEN spans F-3, 20-F, 6-K.
Recent high-impact activity:
- Compugen Files for $400M Universal Shelf, Including $100M ATM Program
- Compugen Reports Strong FY2025 Results, Secures $65M Non-Dilutive Funding, Extends Cash Runway to 2029
- Compugen Reports Strong Q4/FY25 Results, Secures $65M Non-Dilutive Funding, Extends Cash Runway to 2029
Financial Snapshot
Short Interest & Short Volume
12.01 days to coverFINRA reported short interest of 2,366,980 shares in CGEN as of the September 15, 2026 settlement, a 0.8% increase from the prior period — about 12.0 days to cover at its recent average daily volume. On October 2, 2026, 63.3% of CGEN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for CGEN, detected from its recent SEC filings · based on capital-structure filings through 2026-05-18.
Universal Shelf Registration · At-The-Market (ATM) Program
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
CGEN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.